The U.S. Justice Department greenlighted the merger between CVS Health and Aetna with a condition: that Aetna divest its Medicare Part D business to WellCare Health plans. That alleviates the federal government's competition concerns.
The U.S. House of Representatives and Senate have both passed measures to halt the use of "gag clauses" by insurers and pharmacy benefit managers. President Donald Trump is expected to sign the bills soon.
The Senate passed its opioids legislation, laying the groundwork for a final bicameral deal. The upper chamber also cleared a stand-alone healthcare bill to target insurer gag clauses on pharmacists.
The Senate Judiciary Committee kicks off confirmation hearings for Supreme Court nominee Brett Kavanaugh. In Texas, a hearing on the future of the Affordable Care Act takes place.
Cigna's $67 billion acquisition of pharmacy benefit manager Express Scripts must still clear state and federal regulatory hurdles.
As scrutiny tightens on drug middlemen and the significance of their role in spiking drug costs within Medicare Part D, health insurers are hitting back with data that show the most expensive drugs offer the lowest rebates.
Ohio's Medicaid department is directing its managed-care organizations to quit their contracts with pharmacy benefit managers because of opaque pricing practices and strike up new arrangements with transparent vendors.
Activist investor Carl Icahn will no longer urge stockholders to vote down the proposed merger between Cigna Corp. and Express Scripts after two independent advisory firms recommended voters approve the deal.
HHS is taking steps to remove legal protections for drug rebates that favor pharmacy benefit managers. It's unclear whether the changes will actually lead to lower drug prices, experts say.
Antitrust experts and healthcare provider representatives questioned the promised benefits of a proposed merger between pharmacy chain CVS Health and insurer Aetna during a hearing before the California insurance commissioner.
David Cordani doesn't view Cigna as merely a health insurer. The Bloomfield, Conn.-based company, he said, is in the business of delivering "health services." The proposed $54 billion purchase of Express Scripts falls in line with that, he argued.
The administration's proposal, coined American Patients First, recommended bolstering competition, allowing private plans to negotiate discounts for Medicare beneficiaries, creating incentives to lower list prices and reducing consumers' out-of-pocket spending.